EverSource Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-75
| Closed | -$1.56K | – | 4250 |
|
2025
Q1 | $1.56K | Sell |
75
-219
| -74% | -$4.55K | ﹤0.01% | 3046 |
|
2024
Q4 | $6.92K | Buy |
294
+73
| +33% | +$1.72K | ﹤0.01% | 2186 |
|
2024
Q3 | $5.66K | Sell |
221
-594
| -73% | -$15.2K | ﹤0.01% | 2180 |
|
2024
Q2 | $22K | Sell |
815
-875
| -52% | -$23.6K | ﹤0.01% | 1462 |
|
2024
Q1 | $39.4K | Buy |
+1,690
| New | +$39.4K | ﹤0.01% | 1077 |
|
2023
Q2 | – | Sell |
-20
| Closed | -$601 | – | 2498 |
|
2023
Q1 | $601 | Sell |
20
-40
| -67% | -$1.2K | ﹤0.01% | 2188 |
|
2022
Q4 | $1.69K | Hold |
60
| – | – | ﹤0.01% | 1961 |
|
2022
Q3 | $2K | Hold |
60
| – | – | ﹤0.01% | 1621 |
|
2022
Q2 | $2K | Hold |
60
| – | – | ﹤0.01% | 1466 |
|
2022
Q1 | $3K | Hold |
60
| – | – | ﹤0.01% | 1390 |
|
2021
Q4 | $4K | Buy |
+60
| New | +$4K | ﹤0.01% | 1303 |
|